A recent study show that early detection of sub-clinical breast cancer related lymphedema (S-BCRL) using SOZO LDex® reduced the rate of progression to C-BCRL, hence the early adoption of Impedimed’s SOZO BIS technology into the Cancer Rehabilitation & Lymphatic Solutions clinic in Erina. Kate Perkins has outlined some key findings from this study.
